Optogenetic Gene Therapy Partly Restores Sight in Blind Patients
New clinical trial results show optogenetic gene therapy safely restores limited visual function and light sensitivity in patients with advanced retinitis pigmentosa.
Optogenetic Gene Therapy Partly Restores Sight in Blind Patients Read More